Go to the list of all blogs
Sergey Savastiouk's Avatar
published in Blogs
Nov 16, 2026
TickeronGET DAILY SIGNALS
Montauk Renewables (MNTK): Analyst Target at $2.00 Points to +71% Upside Potential

Montauk Renewables (MNTK): Analyst Target at $2.00 Points to +71% Upside Potential

Key Takeaways

  • The $2.00 central target is the arithmetic mean (about $2.03) of four verified analyst price targets, rounded to a clean level.
  • Montauk Renewables, Inc. (MNTK) closed near $1.17, meaning the target requires roughly 71% upside — a very large move.
  • Analyst targets range widely from $1.50 (B. Riley Securities) to $3.00 (Clear Street), reflecting real disagreement about the company's outlook.
  • Key supports include growing renewable natural gas (RNG) production and reaffirmed 2026 revenue guidance; key risks are weak margins, RIN pricing pressure, and execution and liquidity concerns.
  • The stock trades near its 52-week low after a sharp decline, despite a double-digit one-day rebound on its latest earnings report.
  • For more detail on the company's Major News, Today's Price Move, Forecast, and Earnings, visit the dedicated pages.

Analyst Price Targets and Consensus View

Montauk Renewables, Inc. (MNTK) focuses on recovering and processing biogas from landfills and other sources to produce renewable natural gas (RNG) and electricity. I reviewed four current analyst targets: B. Riley Securities at $1.50, UBS at $1.60, Scotiabank at $2.00, and Clear Street at $3.00 with a Buy rating. The average comes to roughly $2.03, which rounds neatly to the $2.00 central target, with the full range spanning $1.50 to $3.00. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.

That spread highlights differing views on the same fundamentals. Most firms in the $1.50–$2.00 range hold neutral ratings, citing margin pressure, softer RIN pricing, and elevated capital needs. Clear Street’s higher target reflects greater optimism on RNG expansion. Several targets have been lowered over the past year, pointing to cautious sentiment overall.

Current Market Position and Path Toward the Target

At a recent close near $1.17, reaching $2.00 would mean about 71% upside. The stock remains well below its 52-week high of roughly $3.28, so even a move to the target would recover only part of the earlier drop. In my view, sustained margin improvement, steadier RIN prices, and solid execution at sites like the Montauk Ag facility in Turkey, North Carolina, would be essential.

The latest quarter showed revenue up about 10.9% year over year, yet net income, adjusted EBITDA, and EPS all came in softer than hoped. Management kept 2026 revenue guidance in the $198 million to $216 million range, which aligns closely with expectations and leaves little room for an immediate positive shift without clearer profitability gains.

What Could Support a Move Toward the Target

  • RNG production growth: Output has been rising, with the GreenWave joint venture adding to revenue.
  • Reaffirmed guidance: Management held 2026 targets steady despite some project delays.
  • Stronger second quarter: Adjusted EBITDA improved sharply year over year, indicating potential operating leverage.
  • Valuation reset: Trading near the 52-week low has created what some see as a more attractive risk-reward setup.
  • Potential RIN recovery: Higher renewable fuel credit prices would directly lift revenue and margins.

What Could Prevent the Target From Being Reached

  • Margin compression: Higher revenue has not translated into better net income or EBITDA, pointing to rising costs.
  • RIN pricing risk: Lower credit prices have driven many target reductions.
  • Execution challenges: The Turkey, North Carolina project has seen delays, and the company has noted liquidity and financing needs.
  • EPS misses: Recent shortfalls underscore forecasting difficulty and may weigh on confidence.
  • Balance sheet pressure: Negative levered free cash flow and higher capital spending limit flexibility.

Technical Levels and Market Structure

The 52-week range of roughly $0.94 to $3.28 sets the technical backdrop. The stock has been consolidating near the bottom, with a post-earnings rebound lifting it from around $0.95 toward $1.37 intraday before settling near $1.17. Support sits at the psychological $1.00 level and the $0.94 low, while $1.50 and $2.00 serve as round-number resistance on any recovery. The longer-term trend remains downward, so clearing several overhead hurdles would be required for a move toward $2.00.

Time Horizon and What Investors Should Monitor

Analyst targets typically look out about 12 months. I’m watching upcoming quarterly results and guidance, RIN and renewable fuel credit trends, progress at the Turkey, North Carolina facility, adjusted EBITDA margins, and any target revisions. Regulatory changes in renewable fuel standards also matter directly to the economics. None of this predicts the target will be reached.

Using AI Tools for Deeper Analysis

From what I see, combining fundamental work with automated signals can help track momentum shifts in real time. I often turn to Tickeron’s AI Daily Buy/Sell Signals when following names like MNTK, as the system monitors thousands of stocks and generates Buy, Sell, or Hold signals based on technical behavior and market conditions. This approach complements the review of analyst targets and earnings data without replacing core research.

Final Assessment

The $2.00 target, derived from averaging four analyst estimates between $1.50 and $3.00, implies roughly 71% upside from near $1.17. Support for reaching it rests on RNG growth, maintained guidance, and possible RIN recovery. Risks center on margin weakness, project execution, liquidity needs, and mixed ratings. Near the 52-week low with cautious sentiment overall, the target represents a high-uncertainty scenario that hinges on margin recovery and successful project delivery in coming quarters.

Exploring Tickeron’s AI Daily Buy/Sell Signals

I’ve found AI Daily Buy/Sell Signals from Tickeron useful for monitoring stocks like MNTK. The platform applies artificial intelligence to scan thousands of equities and ETFs, producing real-time Buy, Sell, or Hold signals based on technical patterns and market shifts. It serves as a practical complement to fundamental analysis when tracking momentum or identifying potential changes in trend.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: MNTK

Contributor

Sergey Savastiouk, Ph.D. has a degree in Applied Mathematics from Moscow University and has extensive experience as an entrepreneur, investor, manager, and mathematician. His professional expertise is in applied mathematics, mathematical modeling, system and pattern analysis, and software and hardware system integration. He has served as the CEO of several hi-tech start-up companies and nonprofit organizations, which has given him proven capabilities in business strategy for high-tech start-up companies, market assessment, company formation, team building, product development, marketing, and sales. He has published numerous articles in journals and magazines on related fields. As a retail investor, he spent 15 years developing his proprietary trading and quantitative algorithms (now Tickeron’s A.I.), which brought him significant returns in trading the stock market. His current work and goal in founding Tickeron is to bring professional, sophisticated stock market analysis capabilities to retail investors via an easy-to-use interface.


MNTK sees MACD Histogram just turned negative

MNTK saw its Moving Average Convergence Divergence Histogram (MACD) turn negative on November 10, 2026. This is a bearish signal that suggests the stock could decline going forward. Tickeron's A.I.dvisor looked at 54 instances where the indicator turned negative. In 50 of the 54 cases the stock moved lower in the days that followed. This puts the odds of a downward move at 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on November 10, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on MNTK as a result. In 75 of 89 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 84%.

MNTK moved below its 50-day moving average on November 10, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for MNTK crossed bearishly below the 50-day moving average on November 10, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 14 of 14 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 90%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where MNTK declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 81%.

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where MNTK's RSI Indicator exited the oversold zone, 27 of 40 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 68%.

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 3 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a +15.35% 3-day Advance, the price is estimated to grow further. Considering data from situations where MNTK advanced for three days, in 221 of 270 cases, the price rose further within the following month. The odds of a continued upward trend are 82%.

MNTK may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of 69 (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.464) is normal, around the industry mean (2.284). P/E Ratio (54.400) is within average values for comparable stocks, (-17.137). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.548). Dividend Yield (0.000) settles around the average of (0.039) among similar stocks. P/S Ratio (1.709) is also within normal values, averaging (48.960).

The Tickeron SMR rating for this company is 87 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Price Growth Rating for this company is 92 (best 1 - 100 worst), indicating slightly worse than average price growth. MNTK’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is 93 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. MNTK’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 84, placing this stock worse than average.

Notable companies

The most notable companies in this group are DuPont de Nemours (NYSE:DD), Chemours Company (The) (NYSE:CC).

Industry description

The specialty chemicals sector includes companies that produce chemicals and industrial gases, which are of relatively high-value, often made to customer specifications. Examples of specialty chemicals are electronic chemicals, industrial gases, coatings, adhesives and sealants, industrial and institutional cleaning chemicals. The products are often valued on the basis of their purposes/performances rather than for their composition. Linde Plc, Ecolab Inc., Air Products and Chemicals, Inc., and Dow, Inc. are some of the largest companies making specialty chemicals.

Market Cap

The average market capitalization across the Chemicals: Specialty Industry is 11.6B. The market cap for tickers in the group ranges from 50 to 237.52B. LIN holds the highest valuation in this group at 237.52B. The lowest valued company is JSCPY at 50.

High and low price notable news

The average weekly price growth across all stocks in the Chemicals: Specialty Industry was -8%. For the same Industry, the average monthly price growth was -7%, and the average quarterly price growth was -13%. GEVO experienced the highest price growth at 18%, while MNTK experienced the biggest fall at -58%.

Volume

The average weekly volume growth across all stocks in the Chemicals: Specialty Industry was -14%. For the same stocks of the Industry, the average monthly volume growth was -17% and the average quarterly volume growth was -16%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 53
P/E Growth Rating: 50
Price Growth Rating: 57
SMR Rating: 78
Profit Risk Rating: 84
Seasonality Score: 1 (-100 ... +100)
AI Screener 3
View a ticker or compare two or three
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

Industry ChemicalsSpecialty

Industry
N/A
Address
5313 Campbells Run Road
Phone
+1 412 747-8700
Employees
189
Web
https://ir.montaukrenewables.com
Interact to see
Advertisement
NVIDIA shares declined roughly 26% over the 30 days ending mid-November, falling from a close near $221 to $162.85. The drop left the stock about 30% below its October 6 record intraday high of $243.37 and at a 52-week low.
Micron shares fell -6.28% to $729.40 from Friday's $778.31 close, gapping lower in premarket trading and holding those losses into Monday's regular session. The decline was sector-driven, not company-specific: memory peers SanDisk, SK hynix and Western Digital slid in tandem as last week's Nvidia CEO departure revived doubts over AI data-center spending, financing and memory demand durability.
SKHY fell -6.87% to $122.74 by 10:04 a.m. ET, down $9.05 from Friday's close of $131.79, extending a premarket decline into the regular session. The drop was driven by a sector-wide AI chip selloff ahead of Nvidia's quarterly results on Tuesday, where CEO Jensen Huang's resignation has raised doubts about the durability of data-center spending that underpins high-bandwidth memory demand.
Dell Technologies (DELL) fell roughly 23.7% over the last 30 days, sliding from a closing price of $451.71 on October 16, 2026, to $344.53 on November 13, 2026. The decline accelerated after the U.S. midterm elections, when investor concerns about potential AI and data-center regulation triggered a sharp sell-off across AI hardware names.
ACHR fell -7.44% in Monday's regular session, sliding from Friday's $4.03 close to $3.73 shortly after 10 a.m. ET — a third consecutive daily decline that pushed shares back toward their November 5 low. No verified news or fundamental catalyst found for today's leg lower; the selling extends the de-rating that followed Q3 results — revenue of just $5.1 million, a net loss widening 111% to $274.6 million, and price-target cuts from Cantor Fitzgerald, Needham and Canaccord.